title: [New drugs for small animals in 2013].
abstract: In 2013, four active pharmaceutical ingredients were released on the German market for small animals. Those are the recombinant human bone morphogenetic protein-2 dibotermin alfa (TruScient®), the ectoparasiticide of the oxadiazine group indoxacarb (Activyl®), the antiepileptic imepitoin (Pexion®) and the angiotensin-II1-receptor antagonist telmisartan (Semintra®). One substance was authorized for an additional species. The prolactin antagonist cabergoline is now also authorized for use in cats. In addition, three active pharmaceutical ingredients, which were approved in 2013 for use in human medicine and are of potential interest to veterinary medicine, are discussed. These are the antineoplastic ingredients dabrafenib, enzalutamide and vismodegib.
authors.affiliation: Dr. Ilka Ute Emmerich, VETIDATA, Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät, Universität Leipzig, An den Tierkliniken 39, 04103 Leipzig, E-Mail: emmerich@vetmed.uni-leipzig.de.
authors.forename: I U
authors.initials: IU
authors.lastname: Emmerich
mesh_terms: D000818:Animals; D002415:Cats; D004285:Dogs; D004345:Drug Industry; D019155:Veterinary Drugs
chemical_list: D019155:Veterinary Drugs
keywords: Drugs; cabergoline; cats; dibotermin alfa; dogs; imepitoin; indoxacarb; registration; telmisartan